{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:05:27Z","timestamp":1789056327305,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pat & Willard Walker Eye Research Center"},{"name":"Jones Eye Institute"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbrc.2020.07.140","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T22:06:50Z","timestamp":1597270010000},"page":"367-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of thalidomide, senicapoc, and sodium butyrate in choroidal neovascularization"],"prefix":"10.1016","volume":"530","author":[{"given":"Valeriy","family":"Lyzogubov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6946-2225","authenticated-orcid":false,"given":"Michael","family":"Dasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini","family":"Bora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puran S.","family":"Bora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.07.140_bib1","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/IAE.0b013e3181f57e30","article-title":"Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives","volume":"30","author":"Zarbin","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.bbrc.2020.07.140_bib2","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1167\/iovs.10-6987","article-title":"Incidence of blindness and severe visual impairment in Germany: projections for 2030","volume":"52","author":"Finger","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2020.07.140_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/07853890600946724","article-title":"Age-related macular degeneration--emerging pathogenetic and therapeutic concepts","volume":"38","author":"Gehrs","year":"2006","journal-title":"Ann. Med."},{"key":"10.1016\/j.bbrc.2020.07.140_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2012.03.018","article-title":"Disparities in adult vision health in the United States","volume":"154","author":"Zambelli-Weiner","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.bbrc.2020.07.140_bib5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1377\/hlthaff.2013.0832","article-title":"Switching to less expensive blindness drug could save medicare part B $18 billion over a ten-year period","volume":"33","author":"Hutton","year":"2014","journal-title":"Health Aff."},{"key":"10.1016\/j.bbrc.2020.07.140_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2019-000398","article-title":"Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review","volume":"4","author":"Khanna","year":"2019","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.bbrc.2020.07.140_bib7","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.178.3.1783","article-title":"CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration","volume":"178","author":"Bora","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2020.07.140_bib8","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ajpath.2014.06.001","article-title":"Complement regulatory protein CD46 protects against choroidal neovascularization in mice","volume":"184","author":"Lyzogubov","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2020.07.140_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0014-5793(03)01110-4","article-title":"Sodium butyrate inhibits angiogenesis of human intestinal microvascular endothelial cells through COX-2 inhibition","volume":"554","author":"Ogawa","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2020.07.140_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/carcin\/23.5.735","article-title":"Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29","volume":"23","author":"Pellizzaro","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2020.07.140_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2184.2000.00173.x","article-title":"Sodium butyrate modulates cell cycle-related proteins in HT29 human colonic adenocarcinoma cells","volume":"33","author":"Coradini","year":"2000","journal-title":"Cell Prolif"},{"key":"10.1016\/j.bbrc.2020.07.140_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2141.2010.08520.x","volume":"153","author":"Ataga","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrc.2020.07.140_bib13","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2002-05-1433","article-title":"ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in\u00a0vitro and in\u00a0vivo in SAD mice","volume":"101","author":"Stocker","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.07.140_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/AAC.01668-15","article-title":"The clinically tested gardos channel inhibitor senicapoc exhibits antimalarial activity","volume":"60","author":"Tubman","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2020.07.140_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.intimp.2014.05.007","article-title":"In\u00a0vitro anti-proliferative and anti-angiogenic activities of thalidomide dithiocarbamate analogs","volume":"21","author":"El-Aarag","year":"2014","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.bbrc.2020.07.140_bib16","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D\u2019Amato","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2020.07.140_bib17","first-page":"2481","article-title":"Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells","volume":"23","author":"Li","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2020.07.140_bib18","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1177\/1078155219827635","article-title":"Continuous angiogenesis inhibition in the treatment for von Hippel-Lindau-related hemangioblastomas of retina and spinal cord","volume":"25","author":"Salim","year":"2019","journal-title":"J.\u00a0Oncol. Pharm. Pract."},{"key":"10.1016\/j.bbrc.2020.07.140_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.critrevonc.2012.10.001","article-title":"Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel-Lindau related hemangioblastomas of the central nervous system","volume":"86","author":"Capitanio","year":"2013","journal-title":"Crit. Rev. Oncol.-Hematol."},{"key":"10.1016\/j.bbrc.2020.07.140_bib20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/bjophthalmol-2016-309319","article-title":"Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome","volume":"101","author":"Yokouchi","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bbrc.2020.07.140_bib21","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1167\/iovs.18-24015","article-title":"Therapeutic effects of a novel phenylphthalimide analog for corneal neovascularization and retinal vascular leakage","volume":"59","author":"Wang","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2020.07.140_bib22","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/jnr.22698","article-title":"Protective effect of thalidomide against N-methyl-D-aspartate-induced retinal neurotoxicity","volume":"89","author":"Takada","year":"2011","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.bbrc.2020.07.140_bib23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.bbrc.2015.08.014","article-title":"Lenalidomide, an anti-tumor drug, regulates retinal endothelial cell function: implication for treating ocular neovascular disorder","volume":"465","author":"Dong","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2020.07.140_bib24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/bjo.2009.158790","article-title":"Intravitreal thalidomide reduces experimental preretinal neovascularisation without induction of retinal toxicity","volume":"94","author":"Vom Hagen","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bbrc.2020.07.140_bib25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00417-008-0781-z","article-title":"The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity","volume":"246","author":"Rabinowitz","year":"2008","journal-title":"Graefe\u2019s archive for clinical and experimental ophthalmology\u00a0= Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"key":"10.1016\/j.bbrc.2020.07.140_bib26","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.febslet.2007.04.024","article-title":"Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin","volume":"581","author":"Bora","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2020.07.140_bib27","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ajpath.2016.03.021","article-title":"The complement regulatory protein CD46 deficient mouse spontaneously develops dry-type Age-related macular degeneration-like phenotype","volume":"186","author":"Lyzogubov","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2020.07.140_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cellbi.2009.04.013","article-title":"Inhibition of new vessel growth in mouse model of laser-induced choroidal neovascularization by adiponectin peptide II","volume":"33","author":"Lyzogubov","year":"2009","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbrc.2020.07.140_bib29","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2353\/ajpath.2010.091168","article-title":"Role of ocular complement factor H in a murine model of choroidal neovascularization","volume":"177","author":"Lyzogubov","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2020.07.140_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited","volume":"29","author":"Anderson","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.bbrc.2020.07.140_bib31","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1016\/j.febslet.2008.09.009","article-title":"Alcohol and nicotine consumption exacerbates choroidal neovascularization by modulating the regulation of complement system","volume":"582","author":"Kaliappan","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2020.07.140_bib32","article-title":"Ginsenoside Rg-1 protects retinal pigment epithelium (RPE) cells from cobalt chloride (CoCl2) and hypoxia assaults","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2020.07.140_bib33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1021\/jm070663s","article-title":"Novel inhibitors of the Gardos channel for the treatment of sickle cell disease","volume":"51","author":"McNaughton-Smith","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.bbrc.2020.07.140_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<411::AID-IJC15>3.0.CO;2-F","article-title":"Hyaluronic acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on a breast-cancer cell line","volume":"81","author":"Coradini","year":"1999","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.bbrc.2020.07.140_bib35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jocn.2009.09.017","article-title":"A\u00a0prospective double-blind, placebo-controlled study of thalidomide sensory symptoms in an elderly population with age-related macular degeneration","volume":"17","author":"Souayah","year":"2010","journal-title":"J.\u00a0Clin. Neurosci. : Off. J. Neurosurg. Soc. Australasia"},{"key":"10.1016\/j.bbrc.2020.07.140_bib36","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/0024-3205(84)90514-9","article-title":"Induction of retinol esterification in retinal pigment epithelial cells by butyrate","volume":"35","author":"Jeng","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2020.07.140_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1208\/s12248-008-9022-y","article-title":"Sodium-coupled monocarboxylate transporters in normal tissues and in cancer","volume":"10","author":"Ganapathy","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.bbrc.2020.07.140_bib38","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1167\/iovs.09-4296","article-title":"VEGF-A165b is cytoprotective and antiangiogenic in the retina","volume":"51","author":"Magnussen","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2020.07.140_bib39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-1549(02)00042-1","article-title":"Antiangiogenesis agents","volume":"15","author":"Ciardella","year":"2002","journal-title":"Ophthalmol. Clin. of North Am."},{"key":"10.1016\/j.bbrc.2020.07.140_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000050875","article-title":"Thalidomide and prednisolone inhibit growth factor-induced human retinal pigment epithelium cell proliferation in\u00a0vitro","volume":"215","author":"Kaven","year":"2001","journal-title":"Ophthalmologica. Journal international d\u2019ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde"},{"key":"10.1016\/j.bbrc.2020.07.140_bib41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1076\/ceyr.19.6.483.5281","article-title":"Effect of thalidomide, octreotide, and prednisolone on the migration and proliferation of RPE cells in\u00a0vitro","volume":"19","author":"Spraul","year":"1999","journal-title":"Curr. Eye Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20315412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20315412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:38:43Z","timestamp":1762094323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20315412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0006291X20315412"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.07.140","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of thalidomide, senicapoc, and sodium butyrate in choroidal neovascularization","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.07.140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}